You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 19, 11 OCT 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Observation
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chronic Rubella Vaccine-Associated Arthropathy

Leslie A. Mitchell, PhD; Aubrey J. Tingle, MD, PhD; Robert Shukin; Jon A. Sangeorzan, MD; Joseph McCune, MD; Daniel K. Braun, MD, PhD

Arch Intern Med. 1993;153(19):2268-2274.


Abstract

Rubella immunization or infection is an uncommonly recognized cause of acute, recurrent, or persistent musculoskeletal manifestations. After routine rubella immunization, two women presented with the onset of polyarthralgia, arthritis, maculopapular rash, fever, paresthesia, and malaise with persistent or recurrent manifestations lasting longer than 24 months after vaccination. The patients expressed rubella virus RNA in peripheral-blood leukocytes 10 and 8 months after vaccination, respectively, in contrast to repeated negative results in asymptomatic rubella-immunized controls. One patient developed significantly depressed antibody responses to rubella virus after vaccination and experienced a prolonged clinical improvement after a 3-month course of intravenous immune globulin. The second patient had normal antibody responses to rubella virus and underwent no clinical improvement during or after intravenous immune globulin therapy. Rubella immunization or infection should be considered as additional causative factors in evaluation of acute and continuing musculoskeletal syndromes.

(Arch Intern Med. 1993;153:2268-2274)



Author Affiliations

From the Departments of Pathology and Pediatrics, University of British Columbia, Vancouver (Drs Mitchell and Tingle and Mr Shukin); and Departments of Internal Medicine (Drs Sangeorzan, McCune, and Braun), and Microbiology and Immunology (Dr Braun), University of Michigan, Ann Arbor.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk of Chronic Arthropathy Among Women After Rubella Vaccination
Ray et al.
JAMA 1997;278:551-556.
ABSTRACT  

Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States
Chen et al.
Pediatrics 1997;99:765-773.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.